BIOVENTIX PLC

Director's Dealing • Oct 18, 2021

National Storage Mechanism | Additional information

Bioventix Plc - Director/PDMR Shareholding

PR Newswire

London, October 18

Bioventix plc

(“Bioventix” or “the Company”)

Director Dealing

Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, announces that the Company was notified on 18 October 2021 that on the same day, Bruce Hiscock, Chief Financial Officer of the Company, purchased a total of 416 ordinary shares of 5 pence each in the Company (“Ordinary Shares”), at an average price of 3,858 pence per Ordinary Share (the “Purchase”).

Following the Purchase, Bruce Hiscock has a beneficial interest in 416 Ordinary Shares, representing approximately 0.01 per cent. of the issued share capital of the Company.

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further details.

For further information please contact:

Bioventix plc Peter Harrison	Chief Executive Officer	Tel: 01252 728 001
finnCap Ltd Geoff Nash/Simon Hicks Alice Lane	Corporate Finance ECM	Tel: 020 7220 0500

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1Details of the person discharging managerial responsibilities / person closely associateda)NameBruce Hiscock2.Reason for the Notificationa)Position/statusChief Financial Officerb)Initial notification/AmendmentInitial notification3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitora)NameBioventix Plcb)LEI213800225MHX7LZQY1084.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducteda)Description of the Financial instrument, type of instrumentOrdinary Shares of 5 pence eachIdentification codeGB00B4QVDF07b)Nature of the transactionPurchase of Ordinary Sharesc)Price(s) and volume(s)

Price(s)	Volume(s)
3,855p	204
3,861p	212

d)Aggregated information:

·     Aggregated volume

·     Price

416

3,858pe)Date of the transaction18 October 2021f)Place of the transactionLondon Stock Exchange, AIM Market (XLON)